1 Min Read
Jan 21 (Reuters) - Symbio Pharmaceuticals Ltd:
* HAS INITIATED A PHASE 1 STUDY IN JAPAN FOR ORAL TREAKISYM IN PATIENTS WITH PROGRESSIVE SOLID TUMORS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.